サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1766962

糖尿病診断の世界市場

Diabetes Diagnostics

出版日
ページ情報
英文 609 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
糖尿病診断の世界市場
出版日: 2025年07月10日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 609 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

糖尿病診断の世界市場は2030年までに594億米ドルに到達

2024年に363億米ドルと推定される糖尿病診断の世界市場は、分析期間2024-2030年にCAGR 8.5%で成長し、2030年には594億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるテストストリップスは、CAGR 8.7%を記録し、分析期間終了時には147億米ドルに達すると予測されます。ランセット分野の成長率は、分析期間中CAGR 7.9％と推定されます。

米国市場は137億米ドルと推定、中国はCAGR10.1％で成長予測

米国の糖尿病診断市場は2024年に137億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに76億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは10.1%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.0％と7.5％と予測されています。欧州では、ドイツがCAGR約8.6%で成長すると予測されています。

世界の糖尿病診断市場動向と促進要因まとめ

糖尿病診断の範囲とその重要性とは？

糖尿病診断は、一般的に糖尿病と呼ばれる高血糖を特徴とする代謝異常の検出とモニタリングに使用される様々な検査と技術を包括しています。早期かつ正確な診断は、糖尿病を効果的に管理し、心臓病、腎不全、視力障害など、関連する多くの健康合併症を予防するために極めて重要です。従来の診断手段には、空腹時血糖検査、2～3ヵ月にわたるグルコースレベルを測定するHbA1c検査、経口ブドウ糖負荷試験などがあります。最近の進歩により、連続グルコースモニタリングシステム（CGMS）やフラッシュグルコースモニターなど、グルコースレベルをリアルタイムで把握し、よりダイナミックな糖尿病管理を可能にするものへと範囲が広がっています。糖尿病の世界の有病率の増加により、糖尿病がもたらす大きな健康的・経済的負担を軽減するために、これらの診断ツールを広く利用することが必要となっています。

技術革新はどのように糖尿病診断を変革しているのか？

技術革新は糖尿病診断を大きく変貌させ、血糖値のモニターをより簡単に、より早く、より低侵襲にします。センサー技術とデジタルヘルスプラットフォームの最新の開発により、頻繁に指で摘むことなくグルコースレベルを継続的に追跡するウェアラブルデバイスが誕生しました。これらのデバイスは、皮下に挿入した微小センサーで間質液中のグルコース濃度を測定し、スマートフォンや専用リーダーにデータを提供することで、グルコースの動向や変動に関するフィードバックを即座に得ることができます。さらに、糖尿病治療における人工知能（AI）の統合により、モニタリング機器の予測機能が強化されつつあり、ユーザーデータや食事・運動などの外的要因を分析することで、高血糖・低血糖イベントの予測・予防に役立っています。このような進歩は、個人の予後を改善するだけでなく、多様な集団における糖尿病の早期発見と継続的な管理を促進することで、より広範な公衆衛生戦略にも貢献しています。

糖尿病診断の実践に影響を与える新たな動向

いくつかの新たな動向が糖尿病診断分野の診療を再構築しています。個別化医療はますます広まりつつあり、個人の遺伝子プロファイルに合わせた診断により、疾患リスクを予測し、それに応じた治療を行う。このアプローチは、データ解析と機械学習の成長によって支えられており、大規模なデータセットを解釈して、より良い治療プロトコルに役立つパターンを発見するのに役立っています。さらに、食事療法、運動療法、メンタルヘルスを含む糖尿病管理に対する総合的なアプローチの一環として診断ツールを導入する統合ケアモデルへのシフトも進んでいます。消費者向け医療技術の動向も重要であり、より多くの患者がモバイルヘルスアプリケーションや接続デバイスを使用して、自分の状態を独自に管理しています。このような動向は、より患者中心のデータ主導型ケアへの移行を強調するものであり、患者をエンパワーし、ヘルスケア提供の効率性を高めるものです。

糖尿病診断市場の成長の原動力は？

糖尿病診断市場の成長は、高齢化や肥満率の増加による糖尿病の世界の有病率の上昇など、いくつかの要因によって牽引されています。認知度の向上とスクリーニングプログラムの充実が診断率の上昇につながり、モニタリング・診断製品に対する需要を高めています。また、精度の向上、利便性、接続性を提供する技術の進歩も極めて重要であり、ライフスタイルにシームレスに適合し、健康を効果的に管理するためのフィードバックを即座に提供する機器を求める患者の要望に応えています。さらに、ヘルスケアプロバイダーは、糖尿病を含む慢性疾患を管理・治療するための費用対効果の高い方法を継続的に模索しており、これが革新的な診断ソリューションへの継続的な投資を支えています。さらに、新規医療機器に対する規制当局の支援や、新興市場におけるヘルスケア・インフラの拡大も、この分野の力強い成長に寄与しています。このようなダイナミクスは、世界のヘルスケア情勢の中で拡大するニーズに対応する上で、イノベーションと適応が果たす重要な役割を浮き彫りにしています。

セグメント

製品タイプ（テストストリップ、ランセット、アナログ血糖モニター、持続血糖モニター、シリンジ、ペン、ポンプ、注射器）、エンドユーザー（病院、在宅医療、診断センター、その他のエンドユーザー）

調査対象企業の例

  • Abbott Laboratories, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • A. Menarini Diagnostics Srl
  • AgaMatrix, Inc.
  • BIONIME Corporation
  • Ascensia Diabetes Care Holdings AG
  • American Laboratory Products Company（ALPCO）
  • AmbiMedInc
  • Companion Medical, Inc.
  • Ciga Healthcare Ltd.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-3404

Global Diabetes Diagnostics Market to Reach US$59.4 Billion by 2030

The global market for Diabetes Diagnostics estimated at US$36.3 Billion in the year 2024, is expected to reach US$59.4 Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Test Strips, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$14.7 Billion by the end of the analysis period. Growth in the Lancets segment is estimated at 7.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$13.7 Billion While China is Forecast to Grow at 10.1% CAGR

The Diabetes Diagnostics market in the U.S. is estimated at US$13.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.6 Billion by the year 2030 trailing a CAGR of 10.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.0% and 7.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.6% CAGR.

Global Diabetes Diagnostics Market - Key Trends & Drivers Summarized

What Is the Scope of Diabetes Diagnostics and Why Is It Crucial?

Diabetes diagnostics encompass a range of tests and technologies used to detect and monitor the metabolic disorder characterized by high blood glucose levels, commonly referred to as diabetes. Early and accurate diagnosis is crucial to managing diabetes effectively and preventing a plethora of associated health complications such as heart disease, kidney failure, and vision impairment. Traditional diagnostic tools include fasting blood sugar tests, HbA1c tests, which measure glucose levels over two to three months, and oral glucose tolerance tests. Recent advancements have expanded the scope to include continuous glucose monitoring systems (CGMS) and flash glucose monitors, which provide real-time insights into glucose levels, enabling more dynamic management of the disease. The increasing prevalence of diabetes globally necessitates widespread access to these diagnostic tools to mitigate the substantial health and economic burdens posed by the disease.

How Are Technological Innovations Transforming Diabetes Diagnostics?

Technological innovations are significantly transforming diabetes diagnostics, making it easier, faster, and less invasive to monitor blood glucose levels. Modern developments in sensor technology and digital health platforms have led to the creation of wearable devices that track glucose levels continuously without the need for frequent finger-pricking. These devices use tiny sensors inserted under the skin to measure glucose levels in interstitial fluid and provide data to smartphones or dedicated readers, allowing for immediate feedback on glucose trends and variability. Additionally, the integration of artificial intelligence (AI) in diabetes care is enhancing the predictive capabilities of monitoring devices, helping to anticipate and prevent hyperglycemic and hypoglycemic events by analyzing user data and external factors such as diet and exercise. These advancements not only improve individual outcomes but also contribute to broader public health strategies by facilitating the early detection and ongoing management of diabetes in diverse populations.

Emerging Trends Influencing Diabetes Diagnostic Practices

Several emerging trends are reshaping practices within the diabetes diagnostics field. Personalized medicine is becoming increasingly prevalent, with diagnostics tailored to individual genetic profiles to predict disease risk and tailor treatments accordingly. This approach is supported by the growth in data analytics and machine learning, which help in interpreting large datasets to uncover patterns that can inform better treatment protocols. Additionally, there is a growing shift towards integrated care models, where diagnostic tools are part of a holistic approach to diabetes management that includes diet, exercise, and mental health. The consumer health technology trend is also significant, with more patients using mobile health applications and connected devices to manage their condition independently. These trends underscore a move towards more patient-centered and data-driven care, which empowers patients and enhances the efficiency of healthcare delivery.

What Drives the Growth of the Diabetes Diagnostics Market?

The growth in the diabetes diagnostics market is driven by several factors, including the rising global prevalence of diabetes due to aging populations and increasing rates of obesity. Enhanced awareness and better screening programs are leading to higher diagnosis rates, thereby increasing the demand for monitoring and diagnostic products. Technological advancements that offer improved accuracy, convenience, and connectivity are also pivotal, as they address patient demands for devices that fit seamlessly into their lifestyles and provide instant feedback to manage their health effectively. Furthermore, healthcare providers are continuously seeking cost-effective ways to manage and treat chronic diseases, including diabetes, which supports ongoing investment in innovative diagnostic solutions. Additionally, regulatory support for novel medical devices and the expansion of healthcare infrastructure in emerging markets contribute to the robust growth of this sector. These dynamics highlight the critical role of innovation and adaptation in meeting the expanding needs within the global healthcare landscape.

SCOPE OF STUDY:

The report analyzes the Diabetes Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps, Injectors); End-Use (Hospitals, Home Care, Diagnostic Centers, Other End-Uses)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 91 Featured) -

  • Abbott Laboratories, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • A. Menarini Diagnostics Srl
  • AgaMatrix, Inc.
  • BIONIME Corporation
  • Ascensia Diabetes Care Holdings AG
  • American Laboratory Products Company (ALPCO)
  • AmbiMedInc
  • Companion Medical, Inc.
  • Ciga Healthcare Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Diabetes: A Chronic Body Disorder
    • An Introduction to Diabetes Diagnostics
    • Diabetes Diagnostics: Easier, Economic, and Efficient Management of the Global Diabetes Epidemic
    • Developed Regions Lead, Developing Economies to Spearhead Future Growth
    • Increase in Number of Hospitals & Diagnostics Centers Augurs Well for Market in Developing Regions
    • Alarming Levels of Diabetes Incidence Worldwide Drives Demand for Diabetes Diagnostic Devices
    • Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
    • Diabetes Emerges as One of the Leading Causes of Mortality
    • Diabetes-Related Deaths as % of Total Deaths in Below 60 Years Population by Region
    • Competition
    • Quality Products at Low Prices: Mantra for Success in the Marketplace
    • SMBG Makers Turn to Mobile Devices to Woo Users on the Move
    • World Brands
    • Recent Market Activity
    • Diabetes Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • High Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Increasing Healthcare Expenditure Aids Diabetes Diagnostics & Testing Market
    • World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021, 2024
    • Increasing Obesity Levels Underpins Market Growth
    • Average Per Capita Annual Health Expenditure (In US$) due to Obesity
    • Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
    • Rising Importance of Real-Time Glucose Sensing and Monitoring Drive Robust Growth in Minimally-Invasive CGM Devices Market
    • Global Continuous Glucose Monitoring Systems Market by Component for 2024
    • CGM Market Breaks through Barriers to Witness Growing Adoption
    • Growing Role of HbA1c Testing Devices in Monitoring & Management of Diabetes
    • Rising Popularity of Near Patient Testing Benefits HbA1c Devices Market
    • Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption
    • Glycated Albumin: A Potential Threat to HbA1c
    • Role of HbA1c Testing in Diabetes Diagnosis and Management
    • HbA1c Tests for Diabetes Diagnosis Need to Address Issues Related to Hemoglobin Variants
    • Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis
    • Despite Competition from CGM Systems and HbA1c Testing Devices, BGM Devices Continues to Witness Demand Growth
    • Blood Glucose Strips: Low Cost Advantage Augurs Drives Market
    • Blood Sugar Lancets Market: Sustained Growth in Demand
    • Self-Monitoring/Household Blood Glucose Sustains Market Growth
    • Rising Smartphone Penetration Augurs Well for SMBG Market
    • Smartphone Penetration Rate as Share of Total Population: 2016-2024
    • Barriers to Adoption of New Technology in BGM Products
    • Accuracy Issues Plague Blood Glucose Meters Market
    • Insulin Pens Rise in Popularity for Administering Insulin
    • Smart Insulin Pens
    • Increasing Role of Self-Injection Devices in Diabetes Management
    • Prefilled Syringe Pen Injectors
    • Human Factors Influence the Design of Self Injection Systems
    • Pain Free Shots: A Growing R&D Domain
    • Undiagnosed Diabetes Emerges as a Major Healthcare Challenge, Translates into Untapped Potential for Diabetes Diagnostics Market
    • Number of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2024
    • Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Diagnostic Devices
    • Innovations & Product Advancements: Prime Focus Area for Vendors
    • Focus on Development of Wearable Devices
    • An Insight into Intriguing Advances in Blood Glucose Monitoring Techniques
    • Companies Develop Innovative Needle-Free Alternatives
    • mHealth Solutions for Diabetes Diagnosis
    • Non-invasive Wearable Glucose Testing Devices
    • Innovations in Insulin Pumps
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Diabetes Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 3: World 16-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Test Strips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Test Strips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 6: World 16-Year Perspective for Test Strips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Lancets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Lancets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 9: World 16-Year Perspective for Lancets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Analog Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Analog Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 12: World 16-Year Perspective for Analog Glucose Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Continuous Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Continuous Glucose Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 15: World 16-Year Perspective for Continuous Glucose Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 18: World 16-Year Perspective for Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 21: World 16-Year Perspective for Pens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 24: World 16-Year Perspective for Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 27: World 16-Year Perspective for Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 30: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 33: World 16-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 36: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 39: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 40: World Diabetes Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • With Diabetes Emerging as a Major Lifestyle Disease, Diabetes Diagnostics Market Poised for Growth in the US
    • Diabetes and Population Statistics in North America and Caribbean Region (2019, 2030 & 2045)
    • Diabetes Prevalence by Ethnicity
    • Aging Demographics: A Factor Driving Diabetes Prevalence
    • Population of 65+ Age Group (in Thousands) in the US for 2019 and 2030
    • North American Aging Population (in Thousands) by Age Group: 1975-2050
    • Diabetes Prevalence in the US: Percentage Share Breakdown of Number of Diabetics by Age Group
    • Rising Significance of Wearable and Non-Invasive Glucose Monitoring Devices
    • Regulatory Guidance for Glucose Meter Companies
    • Insulin Syringes Dominate the Insulin Delivery Devices Market
    • Emerging Grey Market for Testing Strips
    • Competition
    • Companies Focus on Research for Better Diabetes Diagnostics
    • TABLE 41: USA Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • Rising Diabetes Incidence in Canada: Opportunity for Diabetes Diagnostics Market
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • Aging Population Drives Diabetes Diagnostics Market
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • Increasing Diabetes Incidence Drives Market Growth
    • Lower Penetration Offers High Growth Potential
    • TABLE 59: China Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: China 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: China 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • Diabetes Diagnostics Market in Europe: A Promising Outlook
    • Diabetes and Population Statistics in Europe (2019, 2030 & 2045)
    • Reimbursement Scenario
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Diabetes Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: France 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: France 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Italy 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 92: UK Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 95: UK Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: UK Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: UK 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
    • Market Overview
    • Diabetic Foot Ulcers in UK
  • SPAIN
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Spain 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 101: Spain Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Spain Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Spain 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Russia 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 107: Russia Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Russia Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Russia 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Rest of Europe 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • Asia-Pacific: Rising Diabetes Incidence Offers Significant Growth Opportunities
    • Diabetes and Population Statistics in South East Asia (2019 & 2045)
    • Diabetes and Population Statistics in Western Pacific (2019 & 2045)
    • Public and Private Sector Diabetes Care
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Diabetes Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Asia-Pacific 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Australia 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 128: Australia Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Australia Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Australia 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • Expanding Diabetic Population Spurs Growth in the Indian Market
    • Blood Glucose Monitoring Market: An Overview
    • HbA1c Testing Continues to Gain Momentum
    • Glucose Meters Rely on Imported Technology
    • TABLE 131: India Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: India 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 134: India Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: India Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: India 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: South Korea 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 140: South Korea Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: South Korea Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: South Korea 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Asia-Pacific Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Rest of Asia-Pacific 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • Rising Diabetes Cases Present Opportunities for Diabetes Diagnostics in Latin America
    • Diabetes and Population Statistics in South & Central America (2019 & 2045)
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Diabetes Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Latin America 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Latin America Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Latin America 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Argentina 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 161: Argentina Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Argentina Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Argentina 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Brazil 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 167: Brazil Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Brazil Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Brazil 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Mexico 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 173: Mexico Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Mexico Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Mexico 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Rest of Latin America 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Latin America Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Rest of Latin America 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Diabetes Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Diabetes Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Diabetes Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Middle East 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Middle East Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Middle East 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Iran 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 194: Iran Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Iran Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Iran 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Israel 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 200: Israel Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Israel Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Israel 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Saudi Arabia 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Saudi Arabia Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Saudi Arabia 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: UAE 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 212: UAE Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: UAE Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: UAE 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Rest of Middle East 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Rest of Middle East Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Rest of Middle East 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Diabetes Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Diabetes Diagnostics by Product Type - Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 223: Africa 16-Year Perspective for Diabetes Diagnostics by Product Type - Percentage Breakdown of Value Sales for Test Strips, Lancets, Analog Glucose Monitors, Continuous Glucose Monitors, Syringes, Pens, Pumps and Injectors for the Years 2014, 2025 & 2030
    • TABLE 224: Africa Recent Past, Current & Future Analysis for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Africa Historic Review for Diabetes Diagnostics by End-Use - Hospitals, Home Care, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 226: Africa 16-Year Perspective for Diabetes Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care, Diagnostic Centers and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION